SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-20-021151
Filing Date
2020-02-14
Accepted
2020-02-14 11:43:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tm208047-13_sc13ga.htm SC 13G/A 46085
  Complete submission text file 0001104659-20-021151.txt   47592
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Subject) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89486 | Film No.: 20616106
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 3 EAST 28TH STREET, 7TH FLOOR NEW YORK NY 10016
Business Address 3 EAST 28TH STREET, 7TH FLOOR NEW YORK NY 10016 212-426-7040
ARK Investment Management LLC (Filed by) CIK: 0001697748 (see all company filings)

IRS No.: 464309299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A